Open AccessPrevention of COVID-19 in pregnant women, eventual use of new vaccines
Author(s) -
Carlota Cena Cuadra,
Antonio Piga Rivero,
Carlos Cabrera,
Pedro Faneite,
Paulino Vigil-De Gracia
Publication year - 2021
Publication title -
gaceta médica de caracas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.113
H-Index - 5
eISSN - 2739-0012
pISSN - 0367-4762
DOI - 10.47307/gmc.2021.129.2.15
Subject(s) - covid-19 , medicine , pregnancy , fetus , obstetrics , virology , infectious disease (medical specialty) , disease , outbreak , biology , genetics
Pregnant women who have COVID-19 have an increased risk of hospitalization and death; however, there are many restrictions for the application of COVID-19 vaccines on pregnant patients, mainly because there is no confirmation of the safety of their use during pregnancy. None of the vaccines approved to date are based on live attenuated SARS-CoV-2, so the possibility of generating an infection in the fetus is nonexistent.